Corporate DisclosureSQURPHARMA
SQURPHARMA Corporate Disclosure — 11 June 2017
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 11 June 2017. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
The Company has informed that the Board of Directors has approved agreements with M/s. NAAFCO Pharma Ltd. and M/s. Sharif Pharmaceuticals Ltd., Dhaka, Bangladesh for contract manufacturing of some products on behalf of Square Pharmaceuticals Limited to meet increased demand of existing products and to introduce new products.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf0d5a6b00004005f3db
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.